Market Cap 7.93B
Revenue (ttm) 158.32M
Net Income (ttm) -68.92M
EPS (ttm) N/A
PE Ratio 631.29
Forward PE 29.26
Profit Margin -43.53%
Debt to Equity Ratio 1.64
Volume 682,100
Avg Vol 1,933,528
Day's Range N/A - N/A
Shares Out 88.93M
Stochastic %K 84%
Beta 0.58
Analysts Strong Sell
Price Target $81.12

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intr...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 328 4400
Fax: 919 328 4402
Address:
419 Davis Drive, Suite 100, Morrisville, United States
a_f_f_i_z_l_e
a_f_f_i_z_l_e Aug. 7 at 2:16 AM
$MNKD This goes out to @stevemano, lover of all things $LQDA. Someone repost this so he can enjoy the comparison. LOLZ!
1 · Reply
KeelinTime
KeelinTime Aug. 7 at 1:41 AM
0 · Reply
Georgeson
Georgeson Aug. 6 at 5:56 PM
$MNKD To equate $LQDA market cap rise (which led to incredible share price rise) to MNKD market cap rise (which led to essentially flat share price over the last 10 years or just about any period of time) is so stupid that only @NatesNotes can be that stupid to convince suckers to subscribe to his newsletter. Thank you for your attention to this matter. #NateIsAnIdiot #FactsMatter #NumbersDon'tLie
1 · Reply
whiskyqueen
whiskyqueen Aug. 6 at 5:54 PM
$VKTX So we’ve spent the last year or so pounding the table on the possibility of best in class, looking at every angle of this investment. The one and only thing that keeps me up at night that really isn’t discussed on this board, is the possibility of Viking showing superiority over Zep, Reta or even both. What do you think happens when Lilly’s moat is challenged by a little guy? Wouldn’t they unleash legal hell on the patents for Zep to at a bare minimum tie Viking up in court and push their timeline to market back by at the very least a year, even if they know they will lose? Seen it several times over the years, $UTHR and $LQDA come to mind. Is the 2735 patent really bomb proof?
3 · Reply
MarketPro
MarketPro Aug. 6 at 2:13 PM
$LQDA Chart Update:
0 · Reply
iwtd
iwtd Aug. 6 at 2:13 PM
$LQDA - price target of 89$ achieved.
0 · Reply
Gambaa
Gambaa Aug. 6 at 2:05 PM
$LQDA Straight to 100
0 · Reply
Ceherring
Ceherring Aug. 6 at 11:18 AM
0 · Reply
KeelinTime
KeelinTime Aug. 6 at 10:48 AM
0 · Reply
Ceherring
Ceherring Aug. 5 at 9:59 PM
0 · Reply
Latest News on LQDA
Liquidia downgraded to Neutral from Buy at BofA

2026-06-29T10:30:39.000Z - 5 weeks ago

Liquidia downgraded to Neutral from Buy at BofA


Liquidia price target raised to $109 from $59 at BTIG

2026-06-22T11:32:52.000Z - 6 weeks ago

Liquidia price target raised to $109 from $59 at BTIG


Liquidia Transcript: AGM 2026

Jun 16, 2026, 4:30 PM EDT - 7 weeks ago

Liquidia Transcript: AGM 2026


Liquidia announces inclusion in S&P SmallCap 600 Index

2026-06-08T13:08:28.000Z - 2 months ago

Liquidia announces inclusion in S&P SmallCap 600 Index


Liquidia price target raised to $75 from $67 at H.C. Wainwright

2026-06-05T10:55:08.000Z - 2 months ago

Liquidia price target raised to $75 from $67 at H.C. Wainwright


Liquidia rises 17.6%

2026-06-04T16:09:07.000Z - 2 months ago

Liquidia rises 17.6%


Liquidia Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 12:45 PM EDT - 2 months ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2026


Liquidia price target raised to $67 from $55 at H.C. Wainwright

2026-05-12T18:47:33.000Z - 3 months ago

Liquidia price target raised to $67 from $55 at H.C. Wainwright


Liquidia price target raised to $62 from $51 at Wells Fargo

2026-05-12T11:38:21.000Z - 3 months ago

Liquidia price target raised to $62 from $51 at Wells Fargo


Liquidia price target raised to $60 from $57 at Jefferies

2026-05-11T21:57:52.000Z - 3 months ago

Liquidia price target raised to $60 from $57 at Jefferies


Liquidia Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Earnings Call Transcript: Q1 2026


Liquidia Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Earnings release: Q1 2026


Liquidia Quarterly report: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Quarterly report: Q1 2026


Liquidia Slides: Q1 2026

May 11, 2026, 8:30 AM EDT - 3 months ago

Liquidia Slides: Q1 2026


Liquidia reports Q1 EPS 52c, consensus 41c

2026-05-11T11:28:55.000Z - 3 months ago

Liquidia reports Q1 EPS 52c, consensus 41c


Liquidia Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Liquidia Proxy statement: Proxy filing


Liquidia Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

Liquidia Proxy statement: Proxy filing


Liquidia price target raised to $51 from $44 at Wells Fargo

2026-03-23T10:32:21.000Z - 4 months ago

Liquidia price target raised to $51 from $44 at Wells Fargo

INSM


Liquidia price target raised to $19 from $16 at Oppenheimer

2026-03-12T11:52:04.000Z - 5 months ago

Liquidia price target raised to $19 from $16 at Oppenheimer


Liquidia rises 7.7%

2026-03-06T15:06:42.000Z - 5 months ago

Liquidia rises 7.7%


Liquidia price target raised to $55 from $50 at H.C. Wainwright

2026-03-06T11:16:01.000Z - 5 months ago

Liquidia price target raised to $55 from $50 at H.C. Wainwright


Liquidia Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Liquidia Earnings Call Transcript: Q4 2025


Liquidia Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Liquidia Annual report: Q4 2025


Liquidia Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Liquidia Earnings release: Q4 2025


Liquidia Slides: Q4 2025

Mar 5, 2026, 8:30 AM EST - 5 months ago

Liquidia Slides: Q4 2025


Liquidia Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 8:15 PM EST - 7 months ago

Liquidia Slides: 44th Annual J.P. Morgan Healthcare Conference


Liquidia Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 8:00 AM EST - 9 months ago

Liquidia Transcript: Jefferies London Healthcare Conference 2025


Liquidia Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 9 months ago

Liquidia Transcript: UBS Global Healthcare Conference 2025


Liquidia Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

Liquidia Earnings Call Transcript: Q3 2025


Liquidia Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

Liquidia Quarterly report: Q3 2025


Liquidia Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

Liquidia Earnings release: Q3 2025


Liquidia Slides: Q3 2025

Nov 3, 2025, 8:30 AM EST - 9 months ago

Liquidia Slides: Q3 2025


Liquidia Transcript: R&D Day 2025

Oct 28, 2025, 3:00 PM EDT - 10 months ago

Liquidia Transcript: R&D Day 2025


Liquidia Slides: FY 2025

Oct 28, 2025, 3:00 PM EDT - 10 months ago

Liquidia Slides: FY 2025


Liquidia Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q2 2025


Liquidia Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q2 2025


Liquidia Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q2 2025


Liquidia Slides: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Q2 2025


Liquidia Transcript: Status Update

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Transcript: Status Update


Liquidia Slides: Status Update

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Status Update


Liquidia Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q1 2025


Liquidia Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q1 2025


Liquidia Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q1 2025


Liquidia Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing


Liquidia Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing


Liquidia Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q4 2024


Liquidia Annual report: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Annual report: Q4 2024


Liquidia Earnings release: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q4 2024


Liquidia Registration statement: Registration Filing

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Liquidia Registration statement: Registration Filing


Liquidia Slides: FY 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Slides: FY 2025


Liquidia Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 3:00 PM EST - 1 year ago

Liquidia Transcript: Stifel 2024 Healthcare Conference


Liquidia Earnings Call Transcript: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings Call Transcript: Q3 2024


Liquidia Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Quarterly report: Q3 2024


Liquidia Earnings release: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings release: Q3 2024


a_f_f_i_z_l_e
a_f_f_i_z_l_e Aug. 7 at 2:16 AM
$MNKD This goes out to @stevemano, lover of all things $LQDA. Someone repost this so he can enjoy the comparison. LOLZ!
1 · Reply
KeelinTime
KeelinTime Aug. 7 at 1:41 AM
0 · Reply
Georgeson
Georgeson Aug. 6 at 5:56 PM
$MNKD To equate $LQDA market cap rise (which led to incredible share price rise) to MNKD market cap rise (which led to essentially flat share price over the last 10 years or just about any period of time) is so stupid that only @NatesNotes can be that stupid to convince suckers to subscribe to his newsletter. Thank you for your attention to this matter. #NateIsAnIdiot #FactsMatter #NumbersDon'tLie
1 · Reply
whiskyqueen
whiskyqueen Aug. 6 at 5:54 PM
$VKTX So we’ve spent the last year or so pounding the table on the possibility of best in class, looking at every angle of this investment. The one and only thing that keeps me up at night that really isn’t discussed on this board, is the possibility of Viking showing superiority over Zep, Reta or even both. What do you think happens when Lilly’s moat is challenged by a little guy? Wouldn’t they unleash legal hell on the patents for Zep to at a bare minimum tie Viking up in court and push their timeline to market back by at the very least a year, even if they know they will lose? Seen it several times over the years, $UTHR and $LQDA come to mind. Is the 2735 patent really bomb proof?
3 · Reply
MarketPro
MarketPro Aug. 6 at 2:13 PM
$LQDA Chart Update:
0 · Reply
iwtd
iwtd Aug. 6 at 2:13 PM
$LQDA - price target of 89$ achieved.
0 · Reply
Gambaa
Gambaa Aug. 6 at 2:05 PM
$LQDA Straight to 100
0 · Reply
Ceherring
Ceherring Aug. 6 at 11:18 AM
0 · Reply
KeelinTime
KeelinTime Aug. 6 at 10:48 AM
0 · Reply
Ceherring
Ceherring Aug. 5 at 9:59 PM
0 · Reply
Gambaa
Gambaa Aug. 5 at 7:27 PM
$LQDA close over $90 you know you want to
0 · Reply
RichardAnderson681
RichardAnderson681 Aug. 5 at 6:16 PM
$LQDA $ASTX $BLK $PSNL $XLF Liquidia advances pulmonary hypertension therapies, Astex Pharmaceuticals focuses on oncology, BlackRock remains the world's largest asset manager, Personalis advances precision oncology, and XLF tracks major financial institutions.
0 · Reply
grampslol
grampslol Aug. 5 at 2:11 PM
$MNKD what a dog ... $LQDA is flying imo .. #afizzle
0 · Reply
BullRun4
BullRun4 Aug. 5 at 1:34 PM
0 · Reply
stevemano
stevemano Aug. 5 at 1:00 PM
$LQDA wow. 😳. Perhaps we will have a bigger PE ratio today and even more negative EPS! 
2 · Reply
KeelinTime
KeelinTime Aug. 5 at 10:52 AM
0 · Reply
Exelariad
Exelariad Aug. 5 at 10:47 AM
$LQDA $UTHR’s 2026 Q2 Tyvaso Revenues: $452.6 million (down 4%), with growth in Tyvaso DPI offset by declines in Nebulized Tyvaso. $LQDA should have a big run today.
0 · Reply
PatriciaChancey189
PatriciaChancey189 Aug. 5 at 7:30 AM
$LQDA $ASTX $BLK $PSNL $XLF Liquidia advances pulmonary hypertension therapies, Astex Pharmaceuticals focuses on oncology, BlackRock remains the world's largest asset manager, Personalis advances precision oncology, and XLF tracks major financial institutions.
0 · Reply
nnnuuu
nnnuuu Aug. 5 at 7:29 AM
$LQDA $UTHR looking forward to seeing how good weather hindered sales of Tyvaso DPI last Q
0 · Reply
IFeelLucky812
IFeelLucky812 Aug. 5 at 2:26 AM
$LQDA you ever have that stock you bought and just wish you never trimmed your position? My initial stake would be worth 1.1 mill right now 😭😭.
0 · Reply
KeelinTime
KeelinTime Aug. 5 at 12:58 AM
0 · Reply
stevemano
stevemano Aug. 4 at 11:58 PM
$LQDA scam https://youtu.be/o4ltIYhVfx8?is=iH1NxYZlk31D3YfS
0 · Reply